Insuman Rapid Solostar

Insulin human, the active ingredient in Insuman Rapid Solostar, is an insulin presented as a solution for subcutaneous use. It lowers blood glucose in patients with type 1 and type 2 diabetes mellitus.

GNH USA supplies Insuman Rapid Solostar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Rapid Solostar is a rapid‑acting insulin used to manage blood glucose in diabetes mellitus.

- Type 1 diabetes mellitus: provides rapid‑acting insulin to control post‑prandial glucose levels. - Type 2 diabetes mellitus: adds rapid‑acting insulin when oral agents are insufficient to achieve glycaemic targets. - Diabetic ketoacidosis: used as part of insulin therapy to reduce severe hyperglycaemia.

Common Side Effects: - Hypoglycaemia: low blood glucose levels, especially if meals are missed or dosing is excessive. - Injection‑site reactions: redness, swelling, or itching at the injection site. - Weight gain: increased adipose tissue due to improved glucose utilisation. - Lipodystrophy: localized changes in fat tissue with repeated injections. - Edema: mild fluid retention, often in the lower extremities. - Headache: transient mild to moderate headache.

Serious or Rare Side Effects: - Severe hypoglycaemia: neurological impairment, seizures, or loss of consciousness. - Anaphylactic reaction: urticaria, bronchospasm, or angio‑edema requiring emergency treatment. - Hypokalemia: low serum potassium levels, potentially causing cardiac arrhythmias. - Insulin antibody formation: may alter insulin efficacy and cause unpredictable glycaemic control.

Precautions should be taken when using Insuman Rapid Solostar to ensure safe and effective therapy.

- Dose adjustment: modify dose during fasting, illness, or changes in physical activity. - Blood‑glucose monitoring: frequent self‑monitoring is essential to avoid hypoglycaemia. - Renal or hepatic impairment: use with caution and consider reduced dosing. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Rapid Solostar may interact with other medicines, affecting glucose control.

Major Interactions (Avoid): - Beta‑blockers: can mask hypoglycaemia symptoms. - MAO inhibitors: may potentiate insulin’s glucose‑lowering effect. - Thiazide diuretics: can increase blood glucose levels. - Corticosteroids: may raise glucose, requiring higher insulin doses. - Alcohol: can enhance hypoglycaemia risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may increase insulin sensitivity, necessitating dose review. - Oral contraceptives: can affect glucose metabolism. - Thyroid hormones: may alter insulin requirements. - Statins: monitor for rare cases of altered glucose control. - Antidepressants (SSRIs): may influence glycaemic variability.